|

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

RECRUITINGSponsored by National Cancer Centre, Singapore
Actively Recruiting
SponsorNational Cancer Centre, Singapore
Started2015-09-30
Est. completion2026-12-31
Eligibility
Age21 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04340024

Summary

Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.

Eligibility

Age: 21 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with severe side effects from radiotherapy
* Patients with a type of cancer that is associated with sensitivity to radiotherapy

Exclusion Criteria:

* Age of patient must be between 21 (inclusive) and 99 (exclusive)

Conditions4

CancerNasopharyngeal CancerOther CancerProstate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.